Leukoreduction Decreases Alloimmunogenicity of Transfused Murine HOD RBCs.
Hendrickson J, Hod E, Spitalnik S, Hillyer C, Zimring J. Leukoreduction Decreases Alloimmunogenicity of Transfused Murine HOD RBCs. Blood 2009, 114: 640. DOI: 10.1182/blood.v114.22.640.640.Peer-Reviewed Original ResearchWhite blood cellsHOD RBCsPost-transfusion survivalCytometric crossmatchingRBC alloimmunizationLeukoreduction filtersHen egg lysozymeRBC antigensFlow cytometryRBC-specific expressionRed blood cell antigensReductionist murine modelHemolytic transfusion reactionsMinority of miceLateral tail veinAntigen hen egg lysozymeBlood cell antigensEffect of leukoreductionResidual white blood cellsPropridium iodideAltered clearanceHLA alloimmunizationSingle transfusionHLA antigensTransfusion reactionsChapter 42 Neonatal and Pediatric Transfusion Medicine
Hendrickson J, Josephson C. Chapter 42 Neonatal and Pediatric Transfusion Medicine. 2009, 235-239. DOI: 10.1016/b978-0-12-374432-6.00042-7.Peer-Reviewed Original ResearchCardiopulmonary diseaseSevere cardiopulmonary diseaseSmall-volume transfusionsFebrile transfusion reactionsPediatric transfusion medicineHLA alloimmunizationSymptomatic anemiaMajor surgeryPediatric patientsPremature infantsCMV transmissionTransfusion therapyNeonatal patientsPhysiologic changesTransfusion reactionsImmune systemNeonatesFetal periodAnticoagulant-preservative solutionInfantsTransfusionRBC productsTransfusion medicineDlPatientsChapter 46 Transfusion of Patients Undergoing HPC and Solid-organ Transplantation
Hendrickson J, Roback J. Chapter 46 Transfusion of Patients Undergoing HPC and Solid-organ Transplantation. 2009, 269-274. DOI: 10.1016/b978-0-12-374432-6.00046-4.Peer-Reviewed Original ResearchRed blood cellsTransfusion requirementsPlatelet transfusionsBlood productsFebrile non-hemolytic transfusion reactionsNon-hemolytic transfusion reactionsHematopoietic progenitor cell transplantationNon-myeloablative transplantsPreparative conditioning regimenRisk of transfusionSolid organ transplantationType of transplantProgenitor cell transplantationCategory of patientsTransfusion of bloodBlood product selectionFuture platelet transfusionABO mismatchMyeloablative transplantsConditioning regimenTransplant recipientsHLA alloimmunizationTransfusion triggerPlatelet refractorinessCell transplantation